Eucamint

Menthol, Camphor


Indiana Botanic Gardens
Human Otc Drug
NDC 10578-001
Eucamint also known as Menthol, Camphor is a human otc drug labeled by 'Indiana Botanic Gardens'. National Drug Code (NDC) number for Eucamint is 10578-001. This drug is available in dosage form of Ointment. The names of the active, medicinal ingredients in Eucamint drug includes Camphor (synthetic) - 4.35 g/100g Menthol - 2.61 g/100g . The currest status of Eucamint drug is Active.

Drug Information:

Drug NDC: 10578-001
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Eucamint
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Menthol, Camphor
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Indiana Botanic Gardens
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Ointment
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CAMPHOR (SYNTHETIC) - 4.35 g/100g
MENTHOL - 2.61 g/100g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jan, 1995
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 22 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part341
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Indiana Botanic Gardens
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1663849
1663854
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0310578120032
UPC stands for Universal Product Code.
UNII:5TJD82A1ET
L7T10EIP3A
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
10578-001-0257 g in 1 JAR (10578-001-02)01 Jan, 1995N/ANo
10578-001-04114 g in 1 JAR (10578-001-04)01 Jan, 1995N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose topical analgesic topical antitussive

Product Elements:

Eucamint menthol, camphor petrolatum eucalyptus oil peppermint oil citronella oil menthol menthol camphor (synthetic) camphor (synthetic)

Indications and Usage:

Uses temporary relief of minor aches and pains of muscles & joints associated with simple backache, arthritis, bruises, sprains provides cooling pain relief temporarily alleviates and suppresses cough due to minor throat & bronchial irritation associated with a cold or inhaled irritant.

Warnings:

Warnings: for external use only

When Using:

When using this product do not heat do not microwave do not add to hot water or any container when heating water. may cause splattering and result in burns. avoid contact with eyes do not apply to wounds or damaged skin do not bandage tightly do not take by mouth or place in nostrils do not take or give this product for persistent or chronic cough such as occurs with asthma or if cough is accompanied by excessive phlegm (mucous) unless directed by a doctor.

Dosage and Administration:

Directions see the important warnings under "when using this product" adults and children 2 years of age and older: rub on the neck and chest as a thick layer or rub on sore aching muscles. cover with a warm, dry cloth if desired. clothing should be loose about the neck and chest to help vapors reach the breathing passages. use up to three times daily or as directed by a doctor. children under 2 years of age: consult physician.

Stop Use:

Stop use and ask a doctor if muscle aches and pains worsen, or if symptoms persist for more than 7 days or clear up and occur again within a few days cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache. these could be signs of a serious condition.

Package Label Principal Display Panel:

Ndc 10578-001-02 eucamint(r) camphorated cough suppressant pain relieving ointment temporarily alleviates cough due to minor throat & bronchial irritation associated with a cold or inhaled irritants. for the temporary relief of minor aches & pains of muscles & joints net wt 2 oz. image of label

Further Questions:

Questions? 1-800-644-8327 botanicchoice.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.